Pricing Log in Create free account

Burning Rock Biotech Limited Sponsored ADR (BNR) vs Fulgent Genetics, Inc. (FLGT)

Burning Rock Biotech Limited Sponsored ADR and Fulgent Genetics, Inc. are both Diagnostics & Research companies. Fulgent Genetics, Inc. is the larger, with a market value of $513.4M against $116.5M — 4.4× the size. Fulgent Genetics, Inc. grew revenue faster over the last twelve months: 4.67% against −0.14%. Burning Rock Biotech Limited Sponsored ADR has the higher net margin (−13.5% vs −27.5%) and the lower return on invested capital (−50.7% vs −8.22%). Across the 18 metrics below, Fulgent Genetics, Inc. leads on 11 and Burning Rock Biotech Limited Sponsored ADR on 7.

Valuation

Metric BNR FLGT Diagnostics & Research median
P/E n/m n/m 34.52
P/S 19.48 1.56 4.24
P/B 19.57 0.52 3.42
Price to free cash flow n/m n/m 33.51
EV/EBITDA n/m n/m 23.44
EV/Sales 18.64 0.85 5.18
Earnings yield (3.93%) (16.56%) (1.50%)
Free cash flow yield (1.02%) (1.09%) 0.00%

Profitability

Metric BNR FLGT Diagnostics & Research median
Gross margin 74.50% 33.82% 48.32%
Operating margin (12.95%) (39.20%) (5.68%)
Net margin (13.51%) (27.53%) (4.10%)
Free cash flow margin (3.00%) 4.37% 0.00%
Return on equity (13.08%) (8.64%) 0.00%
Return on assets (8.81%) (7.93%) (6.05%)
Return on invested capital (50.66%) (8.22%) 0.00%

Growth

Metric BNR FLGT Diagnostics & Research median
Revenue growth (TTM) (0.14%) 4.67% 8.99%
EPS growth (last fiscal year) 84.16% (39.72%) 20.36%
Revenue growth, 5-year CAGR 3.21% (5.21%) 7.30%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BNR FLGT Diagnostics & Research median
Debt to equity 0.00 0.00 0.01
Current ratio 3.05 5.34 2.27
Net debt to EBITDA 14.48 4.66 0.68

Dividend

Metric BNR FLGT Diagnostics & Research median
Dividend yield — — 0.67%
Payout ratio — — 0.20

Size

Metric BNR FLGT Diagnostics & Research median
Market cap 116.47m 513.43m 2.22b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack